The experiments on dogs and monkeys have shown that the severity of radiation sickness following the exposure to supralethal radiation doses can be predicted by early response of an individual. For such prediction, the most informative criteria include general severity of clinical manifestations during primary radiation response and evaluated within a few post-damage hours, the degree of tension in cardiac rhythm control, the cortisol level, the endocrine status index.

Download full-text PDF

Source

Publication Analysis

Top Keywords

exposure supralethal
8
supralethal radiation
8
radiation response
8
radiation
5
possibility predict
4
predict severity
4
severity individual
4
individual damage
4
damage exposure
4
radiation dosage
4

Similar Publications

Acute nerve agent exposure can kill a person within minutes or produce multiple neurotoxic effects and subsequent brain damage with potential long-term adverse outcomes. Recent abuse of nerve-agents on Syrian civilians, during Japan terrorist attacks, and personal assassinations in the UK, and Malaysia indicate their potential threat to world population. Existing nerve agent antidotes offer only incomplete protection especially, if the treatment is delayed.

View Article and Find Full Text PDF

Optimal triage biodosimetry would include risk stratification within minutes, and it would provide useful triage despite heterogeneous dosimetry, cytokine therapy, mixed radiation quality, race, and age. For regulatory approval, the U.S.

View Article and Find Full Text PDF

Despite remarkable scientific progress over the past six decades within the medical arts and in radiobiology in general, limited radiation medical countermeasures (MCMs) have been approved by the United States Food and Drug Administration for the acute radiation syndrome (ARS). Additional effort is needed to develop large animal models for improving the prediction of clinical safety and effectiveness of MCMs for acute and delayed effects of radiation in humans. Nonhuman primates (NHPs) are considered the animal models that reproduce the most appropriate representation of human disease and are considered the gold standard for drug development and regulatory approval.

View Article and Find Full Text PDF

In the current geopolitical climate there is an unmet need to identify and develop prophylactic radiation countermeasures, particularly to ensure the well-being of warfighters and first responders that may be required to perform on radiation-contaminated fields for operational or rescue missions. Currently, no countermeasures have been approved by the U.S.

View Article and Find Full Text PDF
Article Synopsis
  • Thrombopoietin (TPO) helps make platelets, which are important for blood clotting, and a new drug called JNJ‑26366821 boosts platelet production without causing bad side effects.
  • In tests on mice that got a lot of radiation, JNJ‑26366821 showed it could help them survive and recover better from the effects of the radiation.
  • The drug also improved the health of their bone marrow, which is where blood cells are made, making it a promising treatment for people who might be exposed to radiation in emergencies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!